Scientific research agreement between Foro delle Arti Srl, TES Pharma Srl and Fondo XGEN Venture | Tes Pharma
Summary
The various companies where he acted as manager and founder include Newron now listed in Zurich manufacturer of Xdago, an innovative drug for the treatment of Parkinsons disease; EryDel, set up by Professor Magnani of the Urbino University, with an innovative therapy under development for the treatment of ataxia, a serious rare disease that affects children and for which there is currently no cure.At the same time, Prof. Pellicciari will be appointed Chief Scientific Advisor of TES.Brunello Cucinelli commented as follows: "Science is a noble discipline that has always accompanied the evolution of mankind, placing people at the centre and turning knowledge into a fertile breeding ground for the growth of the human being in harmony with Creation. I see this as consistent with the "care-taking" culture that has always inspired our Solomeo-based company.Therefore, to partner with TES Pharma and Professor Roberto Pellicciari, a scientist friend of mine, as well as with the esteemed XGEN with Paolo Fundar\xf2 and Federica Draghi, is for me a source of great pride and utmost ethical guarantee of harmony between professionalism and humanity. We will endeavour to do "beautiful things" together, under the banner of Human Sustainability".Roberto Pellicciari commented as follows: "For many years I have had the privilege of guiding TES Pharma and its young, talented and passionate researchers in their efforts to discover drugs for diseases for which there is no cure. In this tough journey to the frontiers of therapeutic innovation, I have been supported by Brunello Cucinelli and his family, and in particular Riccardo Stefanelli, in an ongoing engagement between scientific and humanistic approaches, actually two sides of the same coin. My wish is that TES Pharma continues successfully on its science-driven path towards the ever-increasing wellbeing of mankind".Paolo Fundar\xf2 commented as follows: "We have known the TES scientific team for some time and we are thrilled to support the expansion of an Italian excellence in the field of new drug discovery alongside partners of great industrial experience and human depth".Milano, 10 aprile 2024 In un amabile incontro tenutosi questa mattina presso Casa Cucinelli in Milano, alla presenza di amici e giornalisti, Brunello Cucinelli ha illustrato un nuovo, importante progetto per una nobile causa.